MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+34.38%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$559M
AUM Growth
+$559M
(+38%)
Cap. Flow
+$845K
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
ProShares UltraPro Short S&P 500
SPXU
|
$21.1M |
| 2 |
ProShares UltraShort S&P500
SDS
|
$16.9M |
| 3 |
Celldex Therapeutics
CLDX
|
$15M |
Top Sells
| 1 |
Exelixis
EXEL
|
$50.4M |
| 2 |
WisdomTree India Earnings Fund ETF
EPI
|
$965K |
| 3 |
VVUS
Vivus Inc
VVUS
|
$792K |
Sector Composition
| 1 | Healthcare | 87.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $416M | 74.32% | 19,183,713 -2,326,000 | -11% | -$50.4M |
|
2
Alkermes
ALKS
$4.78B
| $60.3M | 10.78% | 1,030,639 | – | – |
|
|
3
ProShares UltraPro Short S&P 500
SPXU
$527M
| $21.1M | 3.77% | +1,230,000 | New | +$21.1M |
|
|
4
ProShares UltraShort S&P500
SDS
$445M
| $16.9M | 3.03% | +1,260,000 | New | +$16.9M |
|
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $15.2M | 2.72% | 630,000 -40,000 | -6% | -$965K |
|
6
iShares MSCI India ETF
INDA
$9.17B
| $15.1M | 2.7% | 480,000 | – | – |
|
|
7
Celldex Therapeutics
CLDX
$1.47B
| $15M | 2.68% | +4,145,900 | New | +$15M |
|
|
VVUS
8
DELISTED
Vivus Inc
VVUS
| – | – | -688,500 | Closed | -$792K |
|